Dubinsky, US
Benjamin Dubinsky, Ivyland, PA US
Patent application number | Description | Published |
---|---|---|
20110276349 | Publishing Templates Having Practice Defined Triggers - A healthcare management system is presented where the management system can include a data routing engine configured to route patient data to various authorized providers as a function of one or more trigger rules. The routing engine can operate as a web portal, through which clients of system can define medical form templates, where a template can include one or more triggering rules that cause further action to take place. When a patient interfaces to the web portal, the portal can render a medical form for the patient based on the template. As the patient interacts with the form, including entering their patient data, the routing engine can determine if any triggering criteria have been satisfied. If so, further actions can place including routing the data to authorized entities or providing notifications. | 11-10-2011 |
Boris Dubinsky, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20120248636 | HEATER UNIT HUMIDIFICATION CHAMBER MONITOR - A heater unit is adapted to determine if a humidification chamber thermally coupled to a hot plate of the heater unit is effectively dry based on determining a thermal response of a hot plate of the heater unit. Also, the activation period during which the hot plate is being heated is adjusted toward an optimum period by adjusting the energization or power level to the heater element thereof in relation to the duration of a prior activation period. Further, the air flow rate of gas through the humidification chamber may be estimated based on a temperature of the hot plate determined in predetermined relationship to the beginning of an activation period. | 10-04-2012 |
Dean V. Dubinsky, Kirkland, WA US
Patent application number | Description | Published |
---|---|---|
20110302399 | Rapid activation of service management processor subsystem for server device - A bootloader process executing on a service management processor (SMP) subsystem for a server device determines whether an initialization flag stored within non-volatile memory of the subsystem is set. The initialization flag corresponds to whether a full cold initialization process of the subsystem is to occur. In response to determining that the initialization flag has not been set, the bootloader process loads an image stored in the non-volatile memory into volatile memory of the subsystem. The image corresponds to processes properly running on the SMP subsystem after the SMP subsystem has booted, including a management process. The processes begin executing on the subsystem. The management process, determines whether a hardware configuration change within the subsystem has been made since when the image was saved to the non-volatile memory. In response to determining that the hardware configuration change has been made, the management process sets the initialization flag and rebooting the subsystem. | 12-08-2011 |
Dean V. Dubinsky, Bellevue, WA US
Patent application number | Description | Published |
---|---|---|
20090113416 | Installation of updated software for server components - A target server is queried to build an inventory of components installed within the target server. The target server has a boot process by which it is employed within a production environment. Updated software is received for each component from an update server, based on the inventory built. The boot process is configured so that the target server installs the updated software for each component the next time it boots, instead of being employed within the production environment. The target server is caused to boot such that it installs the updated software for each component. Upon completion of the target server installing the update software for each component, the boot process is reconfigured so that the next time the target server boots it is again employed within the production environment. The target server is again caused to boot such that it is again employed within the production environment. | 04-30-2009 |
Eric A. Dubinsky, Berkeley, CA US
Patent application number | Description | Published |
---|---|---|
20140200149 | Methods and compositions for identification of source of microbial contamination in a sample - Herein are described 1058 different bacterial taxa that were unique to either human, grazing mammal, or bird fecal wastes. These identified taxa can serve as specific identifier taxa for these sources in environmental waters. Two field tests in marine waters demonstrate the capacity of phylogenetic microarray analysis to track multiple sources with one test. | 07-17-2014 |
Grigory Leonidovich Dubinsky, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20120044498 | Products and Methods for Identifying Rock Samples - Products and methods for identifying rock samples based on an average color value for each rock sample. | 02-23-2012 |
20130156270 | Products and Methods for Identifying Rock Samples - Products and methods for identifying rock samples based on an average color value for each rock sample. | 06-20-2013 |
Leon Dubinsky, Redmond, WA US
Patent application number | Description | Published |
---|---|---|
20100275188 | Intermediate Language Representation and Modification - A system and method for facilitating analysis and modification of a computer program. A directed graph is generated from an intermediate language representation of a computer program function, with a node representing each instruction. Meta-edges or meta-nodes are inserted into the directed graph to facilitate location of instruction nodes. One type of meta-edge is a back edge that identifies branch instruction nodes. Some meta-nodes may identify instructions of a specific type. Some meta-nodes may identify exception blocks and corresponding handlers. Analysis of a program function may include insertion of new instructions prior to execution of the function. | 10-28-2010 |
Leonid Dubinsky, Redmond, WA US
Patent application number | Description | Published |
---|---|---|
20100138817 | IN-PLACE FUNCTION MODIFICATION - Modifying computer program code can be performed at or immediately prior to runtime of the computer code in a runtime environment of a common language infrastructure of a language-neutral framework for developing and executing computer applications. A function in a computer program can be modified at runtime by injecting arbitrary code, while mitigating an alteration of a program's call stack. A just-in-time compilation service is used to compile and execute intermediate language code of the program, and the runtime environment sends callback functions to an event-based profiling agent (profiler) attached to the runtime environment. The profiler can trap desired functions, as determined by configuration data, and inject modification code from stub methods in a stub assembly file. The modified code can be sent back to the runtime environment to be executed by the just-in-time compilation service. | 06-03-2010 |
20120151450 | Platform-Agnostic Diagnostic Data Collection and Display - A data collection system may instrument and collect data from arbitrary executable code by loading the executable code into memory and instrumenting the code according to monitoring conditions. The instrumentation may include pointers or bindings to a data collector that may gather and store information when the monitoring condition exists. A display module may allow a programmer to browse the results. The data collection system may operate on any type of native code or intermediate code and may operate with or without symbol tables. | 06-14-2012 |
Marla Dubinsky, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20100015156 | DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE IN CHILDREN - This invention provides methods of diagnosing and predicting disease progression of Crohn's disease. In one embodiment, a method of the invention is practiced by determining the presence or absence of CARD15 variants R702W, G908R, and/or 1007insC in a pediatric individual. In another embodiment, a method of the invention is practiced by determining the presence or absence of anti-Cbir1, anti-OmpC, ASCA, and/or pANCA in a pediatric individual | 01-21-2010 |
20100190162 | METHODS OF USING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE TL1A GENE TO PREDICT OR DIAGNOSE INFLAMMATORY BOWEL DISEASE - This invention provides methods of diagnosing or predicting susceptibility to Inflammatory Bowel Disease by determining the presence or absence of genetic variants in the TL1A gene. In one embodiment, a method of the invention is practiced by determining the presence or absence of TL1A production following Fc-gamma-R activation. In another embodiment, the invention provides methods of treatment of inflammatory bowel disease by inhibition of TL1A. | 07-29-2010 |
20110229471 | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNF ALPHA THERAPY IN INFLAMMATORY BOWEL DISEASE - The present invention relates to methods of prognosing responsiveness to anti-TNFα therapy by determining the presence or absence of risk factors in the individual. In one embodiment, the risk factors are genetic markers, serological markers and/or clinical phenotypes associated with non-responsiveness to treatment with anti-TNFα therapy in an individual diagnosed with IBD. | 09-22-2011 |
20120073585 | METHODS OF PREDICTING COMPLICATION AND SURGERY IN CROHN'S DISEASE - The present invention relates to prognosing, diagnosing and treating an aggressive form of Crohn's disease characterized by rapid progression to complication and/or surgery from the time of diagnosis. In one embodiment, the prognosis, diagnosis and treatment is based upon the presence of one or more genetic risk factors. | 03-29-2012 |
20120190698 | METHODS OF PREDICTING THIOPURINE RESPONSE - The present invention relates to methods of predicting therapeutic efficacy of thiopurines in an individual by determining the presence of one or more risk variants. In one embodiment, the effective therapeutic efficacy of thiopurines is determined by the presence of risk variants at the genetic loci of HLA-DRB1, CREM, TAGAP, PLCL1, GPX4, SBNO2, MEF2A and/or LYSMD4. In another embodiment, the risk variants are located at the genetic loci of ARL4C, IL1R2, JAK2, 19q13, CARD9, SNAPC4, and/or 8q24. In another embodiment, the individual is has been diagnosed with inflammatory bowel disease. | 07-26-2012 |
Marla C. Dubinsky, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20120208900 | METHODS OF PREDICTING THE NEED FOR SURGERY IN CROHN'S DISEASE - The present invention relates to methods of predicting susceptibility to a severe form of Crohn's disease in an individual by determining the presence or absence of one or more risk variants. In one embodiment, the risk variants comprise a combination of genetic risk variants and clinical risk factors. In another embodiment, the genetic risk variants are at the IL12B genetic locus. In another embodiment, the severe form of Crohn's disease is characterized by a rapid progression to a condition requiring surgery for treatment. | 08-16-2012 |
20140018447 | METHODS OF DIAGNOSING AND TREATING INTESTINAL GRANULOMAS AND LOW BONE DENSITY IN INFLAMMATORY BOWEL DISEASE - The present invention relates to methods of diagnosing inflammatory bowel disease (IBD) in an individual by determining the presence of at least one risk genetic variant and/or at least one risk serological marker. In one embodiment, the presence of at least one risk genetic variant is indicative of granuloma. In another embodiment, the presence of at least one risk genetic variant is indicative of low bone density (LBD). | 01-16-2014 |
William J. Dubinsky, Hoboken, NJ US
Patent application number | Description | Published |
---|---|---|
20090204235 | TRIGGERING AND ACTIVATING DEVICE FOR TWO COUPLED CONTROL SYSTEMS THAT CAN BE MUTUALLY ACTIVATED, AND CORRESPONDING METHOD - A triggering and activating device and an automated process coupling two reciprocally activatable monitoring devices or operational-intervention devices. A first synchronizing module synchronizes transmissible operational-intervention parameters of a lookup table with operational devices assigned to the first monitoring device, and a second synchronizing module synchronizes storable threshold-value parameters for activating the second monitoring device. Physical measuring parameters of intervention events are detected and transmitted to the activating device, an intervention-event stack being correspondingly incremented by a first filter module based on the physical measuring parameters and a dynamically implemented weighting of the lookup table. By the first filter module, based on the synchronized threshold parameters and the intervention-event stack, corresponding activating parameters are generated and, if the activating parameters exceed the predetermined threshold value, the second monitoring device is activated by an activating unit and a corresponding activating pulse. | 08-13-2009 |
William Jay Dubinsky, Hoboken, NJ US
Patent application number | Description | Published |
---|---|---|
20090054079 | Electronic control apparatus and method for controlling alarm systems of cellular structure - Electronic control apparatus ( | 02-26-2009 |
William P. Dubinsky, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20080305498 | Biomarkers for Use in Vessel Disorders - The present invention relate to a method of diagnosing a subject having a vessel disorder. More particularly, a biological sample is obtained from a subject suspected of having a vessel disorder. A protein profile is determined or measured in the sample using procedures described herein, for example, mass spectrometry or immunodetection. The protein profile from the subject is compared to a protein profile in a healthy control, wherein an alteration in the levels of a protein of the profile in the subject compared to the healthy control is indicative of a vessel disorder. | 12-11-2008 |
20100279419 | DETECTION OF SALIVA PROTEINS MODULATED SECONDARY TO DUCTAL CARCINOMA IN SITU OF THE BREAST - A method of differentiating among the presence of ductal carcinoma in situ in the breast, benign fibroadenoma of the breast, and non-cancerous breast tissue in a subject is disclosed. The method comprises: measuring the concentration of at least one protein biomarker selected from a group of forty-nine differentially expressed proteins in the saliva of persons with DCIS, or benign fibroadenoma, or in persons who are cancer-free. The resulting test data is compared to a reference panel. From the comparison the presence in the subject of either ductal carcinoma in situ of the breast, or benign fibroadenoma of the breast is determined. | 11-04-2010 |
20130116343 | Salivary Protein Markers for Detection of Breast Cancer - A method of diagnosing a patient's risk of breast cancer comprises measuring in a saliva sample from the patient a concentration of at least a first protein marker, wherein the first protein marker is either ubiquitin or cytochrome p450, to provide a set of test data comprising a concentration value of each protein marker in the saliva sample. The test values are then compared to a reference panel comprising a Reference Control Value and a Reference Breast Cancer Value, and a diagnosis of either increased or decreased risk of breast cancer is determined for the patient based on a result of that comparison. A test kit for identifying a person at increased risk of breast cancer is also provided. | 05-09-2013 |
20130280743 | DETECTION OF SALIVA PROTEINS MODULATED SECONDARY TO DUCTAL CARCINOMA IN SITU OF THE BREAST - A method of differentiating among the presence of ductal carcinoma in situ in the breast, benign fibroadenoma of the breast, and non-cancerous breast tissue in a subject is disclosed. The method comprises: measuring the concentration of at least one protein biomarker selected from a group of forty-nine differentially expressed proteins in the saliva of persons with DCIS, or benign fibroadenoma, or in persons who are cancer-free. The resulting test data is compared to a reference panel. From the comparison the presence in the subject of either ductal carcinoma in situ of the breast, or benign fibroadenoma of the breast is determined. | 10-24-2013 |
Zarema Dubinsky, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20100246325 | Method and Apparatus for Acoustic Impedance and P-Wave Anisotropy Measurements - Measurements of impedance are made using a piezoelectric transducer oriented at different angles to a formation bedding plane. The impedance measurements are then used to estimate the anisotropic velocity of the formation. | 09-30-2010 |
20100254218 | Method and Apparatus for Estimating Formation Permeability and Electroacoustic Constant of an Electrolyte-Saturated Multi-Layered Rock Taking Into Account Osmosis - An acoustic source on a logging tool is used to generate acoustic waves in a borehole. Acoustic detectors on the logging tool measure the generated acoustic waves. Electrodes on the logging tool are used to measure the potential resulting from the generated acoustic wave. The output of the hydrophones and the electrodes corresponding to Stoneley wave components of the acoustic wave are processed to provide an estimate of formation permeability, acoustoelectric constant, and a velocity of a propagating second compressional wave in the formation. | 10-07-2010 |
20110012602 | Cancellation of Vibration Noise in Deep Transient Resistivity Measurements While Drilling - A transient electromagnetic (TEM) signal is recorded in an earth formation during vibration of a logging tool. Concurrently, accelerometer measurements are made. The accelerometer measurements are used to correct the TEM signal for the vibration using the accelerometer measurement and a transfer function relating the TEM signal and the accelerometer. The transfer function may be determined using measurements in a water tank or by using the tail end of the TEM measurements. | 01-20-2011 |
20120109528 | RADON MIGRATION OF ACOUSTIC DATA - Disclosed is a method implemented by a processor for imaging a formation penetrated by a borehole. The method includes: obtaining acoustic data in a depth-time domain using an acoustic downhole tool disposed at a depth in the borehole, the acoustic downhole tool having an acoustic source and an acoustic receiver; transforming the acoustic data in the depth-time domain into a Radon domain using a Radon transform; filtering the acoustic data in the Radon domain to increase a signal of interest in the acoustic data in the Radon domain; determining a location of a point in the formation that reflected acoustic energy emitted from the acoustic source to the acoustic receiver, the location of the point being represented in the Radon domain; and inverting the location of the point represented in the Radon domain into a radius-depth domain to image the formation. | 05-03-2012 |